Rare disease CRO market to reach $3.16 billion by 2030 at an 8.9% CAGR, driven by orphan drug development, precision medicine, and decentralized clinical trials.
Radiopharmacies market to reach $15.26 billion by 2030 at 8.2% CAGR, driven by rising prevalence of cancer and chronic diseases and increasing demand for nuclear medicine.
Precision Cancer Imaging market to reach $31.71 billion by 2030 at 12.8% CAGR, driven by increasing cancer prevalence and demand for personalized oncology treatments.
Pancreatic Stone Protein Testing market to reach $1.77 billion by 2030 at 7.8% CAGR, driven by rising hospital-acquired infections and POCT expansion.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.